Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine
Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
This is an extension study for participants aged 6 to 17 with migraine who completed either studies 19356A (NCT04965675) (chronic migraine [CM] study in adolescents) or 19357A (episodic migraine [EM] study in children and adolescents). All participants who complete the Week 12 visit of the respective lead-in study will be offered participation in this open-label extension (OLE) study, unless there is a safety concern precluding a participant's participation in the study. Participants originally randomized to 100 milligrams (mg) (weight adjusted) in the double-blind lead-in study (Study 19356A or Study 19357A) will continue on the same dose (100 mg, weight adjusted) in the OLE study. Participants randomized to the 300 mg dose (weight adjusted) in the double-blind lead-in study will continue on 300 mg (weight adjusted) in the OLE study. Participants who were assigned to placebo in the double-blind lead-in study will be randomly allocated to one of the two treatment groups: eptinezumab 100 mg (weight adjusted) or eptinezumab 300 mg (weight adjusted) with a ratio of 1:1.
Inclusion Criteria:
- The participant must have completed Week12 (completion) visit of either Study19356A (CM) or Study19357A (EM) immediately prior to enrolment into this OLE study.
Exclusion Criteria:
HQ_Medinfo@Lundbeck.com+45 36301311
Stamford, Connecticut 06905-1206, United States
East Lansing, Michigan 48824-7015, United States
Charlotte, North Carolina 28211-5027, United States
Cincinnati, Ohio 45229-3026, United States
Córdoba-Barrio Crisol, Córdoba Province X5014AKM, Argentina
San Miguel de Tucumán, Tucumán Province T4000AXL, Argentina
Cagliari, Sardinia 09121, Italy
Pisa, Tuscany 56126, Italy
Guadalajara, Jalisco 44700, Mexico
Ampl San Lucas Tepetlacalco, State of Mexico 54055, Mexico
Krakow, Lesser Poland Voivodeship 30-363, Poland
Oświęcim, Lesser Poland Voivodeship 32-600, Poland
Wroclaw, Lower Silesian Voivodeship 52-210, Poland
Almada, Setúbal District 2805-267, Portugal
Porto Covo, Setúbal District 4050-651, Portugal
Eskişehir, 26480, Turkey (Türkiye)
Edinburgh, Midlothian EH16 4TJ, United Kingdom
Great Yarmouth, Norfolk NR31 6LA, United Kingdom